Drug and Medication Analysis & Statistics in Europe Countries, March 2015

1-30 of 96 reports

Purchase Reports From Reputable Market Research Publishers

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...

  • Industries : Drug and Medication
  • Countries : Romania
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Bulgaria’s pharmaceutical industry will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Poland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Poland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe the impact of the Drug Reimbursement Act will lead to an ...

  • Industries : Drug and Medication
  • Countries : Poland
Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Germany
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...

  • Industries : Drug and Medication
  • Countries : Hungary
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Based on Croatia’s deteriorating macroeconomic outlook, combined with our expectations that the new Kukuriku coalition government will pursue more severe austerity measures and the fact the ...

  • Industries : Drug and Medication
  • Countries : Croatia
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: The EU/IMF economic rescue package, approved in May 2011, has widespread implications for the pharmaceutical segment, including changes to reimbursement, the obligation to prescribe by active ...

  • Industries : Drug and Medication
  • Countries : Portugal
Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. ...

  • Industries : Drug and Medication
  • Countries : Greece
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Moldova’s small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination for investment. However, it is the most liberal country in the Commonwealth ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

The Czech Republic retains its pole position in BMI’s Q111 Regional Business Environment Ratings (BERs) for Emerging Europe. In our global table, the Czech Republic moved upward, placing 12th, now being ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Demographic considerations – in combination with concerted cost-containment pressures that form part of fiscal austerity measures – will continue to hamper the development of the Lithuanian ...

  • Industries : Drug and Medication
  • Countries : Lithuania
Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to receive ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Renewed liberalisation of Russia’s pharmaceutical industry could follow the final approval of the country’s membership of the World Trade Organisation (WTO) at the end of 2011. Liberalisation ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The expected growth of Belgium’s ageing population will have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than young people due ...

  • Industries : Drug and Medication
  • Countries : Belgium
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. ...

  • Industries : Drug and Medication
  • Countries : Belarus
Finland Pharmaceuticals and Healthcare Report Q1 2015

Finland Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Finland, like many other Western countries, has a mature pharmaceutical market where growth is slowing. Although an ageing population will drive the demand ...

  • Industries : Drug and Medication
  • Countries : Finland
United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare markets of the United Kingdom are driven by government spending in the form of the National Health System (NHS), which accounts ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: It is our view that the Swiss economy will record slower growth in 2012. This may lead to the implementation of more austerity measures which will impact the publicly funded pharmaceuticals and ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 208
  • Industry report
  • April 2015
  • by Business Monitor International

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical industry performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and ...

  • Industries : Drug and Medication
  • Countries : Latvia
Austria Pharmaceuticals and Healthcare Report Q2 2015

Austria Pharmaceuticals and Healthcare Report Q2 2015

  • $ 1 208
  • Industry report
  • April 2015
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. Our updated ...

  • Industries : Drug and Medication
  • Countries : Austria
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Poland Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Poland Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Poland is an important pharmaceutical industry in Central and Eastern Europe (CEE), and is a relatively well-developed industry compared with those to the east. Poland’s total drug expenditure and projected ...

  • Industries : Drug and Medication
  • Countries : Poland
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: We continue to see strong short and medium-term growth potential for the Ukrainian pharmaceutical industry, with the caveat that the industry faces severe and ever-present economic risks strongly ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Austria Pharmaceuticals and Healthcare Report Q1 2015

Austria Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. While the ...

  • Industries : Drug and Medication
  • Countries : Austria
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: While we lowered our projections for Hungary's pharmaceutical industry in response to the government's structural reform programme at the start of 2011, we continue to believe the reported magnitude ...

  • Industries : Drug and Medication
  • Countries : Hungary
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Latvia’s attractiveness to multinationals will continue to be negatively impacted by the government’s cost-containment measures and the wider macroeconomic performance, especially as much ...

  • Industries : Drug and Medication
  • Countries : Latvia
Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the industry . BMI believes the current form of the legislation is overly simplistic and punishes ...

  • Industries : Drug and Medication
  • Countries : Romania
About 2 100 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in the UK

  • February 2015
    5 pages
  • Vaccine  

    Pertussis Vacci...  

  • United Kingdom  

    Europe  

View report >

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.